companydata.dkcompanydata.dk

ENDOGEN ApS: Financial statements 2021

CVR: 29813337

Source: annual report 2021, Danish Business Authority

27/10/202026/10/2021

ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -23,164 and a net result of DKK -24,464 compared with DKK -18,432 the year before. Equity in the 2021 report amounted to DKK 54,374. The solvency ratio was 61.2%. The company had 1 employee in the financial year.

Gross Profit
DKK -23,164
Profit/Loss
DKK -24,464
Equity
DKK 54,374
Total Assets
DKK 88,852
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--23 t.-24 t.54 t.1
2020--18 t.-18 t.79 t.1
2019--48 t.-49 t.97 t.1
2018--26 t.-26 t.83 t.1
20170-7 t.-7 t.36 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ENDOGEN ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

ENDOGEN ApS: The 2020 annual report is outMar 26, 2021

ENDOGEN ApS has published its annual report for 2020. Gross profit came to DKK -18,293, and the net result was DKK -18,432.

About ENDOGEN ApS

ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.

Source: annual report 2025, Danish Business Authority